Bioethics, Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 0.02862 million compared to USD 0.029883 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.03 a year ago.
For the six months, net loss was USD 0.050299 million compared to USD 0.058058 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.05 a year ago.